APA (7th ed.) Citation

A, T., EI, I., Y, W., T, H., PI, K., N, Z., . . . G, S. (2026). RNA-LNP-mediated in vivo prime editing corrects disease phenotypes in a mouse model of citrullinemia type I. Science translational medicine, 18(849), eaec7274. https://doi.org/10.1126/scitranslmed.aec7274

Chicago Style (17th ed.) Citation

A, Tálas, et al. "RNA-LNP-mediated in Vivo Prime Editing Corrects Disease Phenotypes in a Mouse Model of Citrullinemia Type I." Science Translational Medicine 18, no. 849 (2026): eaec7274. https://doi.org/10.1126/scitranslmed.aec7274.

MLA (9th ed.) Citation

A, Tálas, et al. "RNA-LNP-mediated in Vivo Prime Editing Corrects Disease Phenotypes in a Mouse Model of Citrullinemia Type I." Science Translational Medicine, vol. 18, no. 849, 2026, p. eaec7274, https://doi.org/10.1126/scitranslmed.aec7274.